Login to Your Account



J&J expands efforts in HBV, inks partnership with China's CTTQ

By Cornelia Zou
Staff Writer

Thursday, January 7, 2016

HONG KONG – Looking to further its innovative efforts in drug development, pharma major Johnson & Johnson has partnered with Chinese liver disease expert Chia Tai Tianqing Pharmaceutical Group Co. Ltd., as well as a score of other external companies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription